DK1994152T3 - Peptider der er effektive i behandlingen af tumorer og andre tilstande der kræver fjernelse eller destruktion af celler - Google Patents
Peptider der er effektive i behandlingen af tumorer og andre tilstande der kræver fjernelse eller destruktion af cellerInfo
- Publication number
- DK1994152T3 DK1994152T3 DK07710660.7T DK07710660T DK1994152T3 DK 1994152 T3 DK1994152 T3 DK 1994152T3 DK 07710660 T DK07710660 T DK 07710660T DK 1994152 T3 DK1994152 T3 DK 1994152T3
- Authority
- DK
- Denmark
- Prior art keywords
- tumors
- destruction
- treatment
- cell removal
- conditions requiring
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 230000006378 damage Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77693306P | 2006-02-28 | 2006-02-28 | |
| PCT/CA2007/000318 WO2007098588A1 (en) | 2006-02-28 | 2007-02-28 | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1994152T3 true DK1994152T3 (da) | 2013-03-11 |
Family
ID=38458614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07710660.7T DK1994152T3 (da) | 2006-02-28 | 2007-02-28 | Peptider der er effektive i behandlingen af tumorer og andre tilstande der kræver fjernelse eller destruktion af celler |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8067378B2 (da) |
| EP (1) | EP1994152B1 (da) |
| JP (1) | JP2009528298A (da) |
| KR (1) | KR20080110765A (da) |
| CN (1) | CN101389760A (da) |
| AU (1) | AU2007219669A1 (da) |
| BR (1) | BRPI0708340A2 (da) |
| CA (1) | CA2643100A1 (da) |
| DK (1) | DK1994152T3 (da) |
| EA (1) | EA200801853A1 (da) |
| ES (1) | ES2400920T3 (da) |
| MX (1) | MX2008010942A (da) |
| PL (1) | PL1994152T3 (da) |
| PT (1) | PT1994152E (da) |
| SI (1) | SI1994152T1 (da) |
| WO (1) | WO2007098588A1 (da) |
| ZA (1) | ZA200807394B (da) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1994152T3 (da) * | 2006-02-28 | 2013-03-11 | Nymox Corp | Peptider der er effektive i behandlingen af tumorer og andre tilstande der kræver fjernelse eller destruktion af celler |
| US20080027005A1 (en) * | 2006-07-31 | 2008-01-31 | Paul Averback | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| EP3191131A4 (en) | 2014-08-21 | 2018-09-05 | The General Hospital Corporation | Tumor necrosis factor superfamily and tnf-like ligand muteins and methods of preparing and using the same |
| US20160215031A1 (en) * | 2015-01-27 | 2016-07-28 | Nymox Pharnaceutical Corporation | Method of treating disorders requiring destruction or removal of cells |
| US20160361380A1 (en) * | 2015-06-12 | 2016-12-15 | Nymox Corporation | Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations |
| US11628202B2 (en) * | 2015-07-24 | 2023-04-18 | Nymox Corporation | Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia |
| US10183058B2 (en) * | 2016-06-17 | 2019-01-22 | Nymox Corporation | Method of preventing or reducing the progression of prostate cancer |
| US10172910B2 (en) * | 2016-07-28 | 2019-01-08 | Nymox Corporation | Method of preventing or reducing the incidence of acute urinary retention |
| US10532081B2 (en) * | 2016-09-07 | 2020-01-14 | Nymox Corporation | Method of ameliorating or preventing the worsening or the progression of symptoms of BPH |
| US10835538B2 (en) | 2018-03-28 | 2020-11-17 | Nymox Corporation | Method of treating benign prostatic hyperlasia with antibiotics |
| US20200061150A1 (en) | 2018-08-23 | 2020-02-27 | Nymox Corporation | Method of inducing selective prostate glandular pharmaco-ablation with sparing of nerves and preservation of sexual function |
| US20200360466A1 (en) | 2019-05-13 | 2020-11-19 | Nymox Corporation | Method of improving lower urinary tract symptoms |
| US11298400B2 (en) | 2019-05-13 | 2022-04-12 | Nymox Corporation | Method of enhancing the therapeutic efficacy of fexapotide triflutate in treating LUTS |
| US11278588B2 (en) | 2019-05-13 | 2022-03-22 | Nymox Corporation | Method of treating lower urinary tract symptoms with fexapotide triflutate |
| US11231421B2 (en) | 2019-07-31 | 2022-01-25 | Nymox Corporation | Methods of treating multifocal cancer |
| US11331374B2 (en) | 2019-07-31 | 2022-05-17 | Nymox Corporation | Focal treatment of prostate cancer |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4752602A (en) * | 1985-09-09 | 1988-06-21 | Board Of Regents, The University Of Texas System | Dipeptide alkyl esters and their uses |
| US6916605B1 (en) * | 1990-07-10 | 2005-07-12 | Medical Research Council | Methods for producing members of specific binding pairs |
| WO1994023756A1 (en) | 1993-04-20 | 1994-10-27 | The General Hospital Corporation | Neural thread protein gene expression and detection of alzheimer's disease |
| CU22921A1 (es) * | 1999-11-16 | 2004-02-20 | Centro Inmunologia Molecular | Anticuerpos quimérico, humanizado y el fragmento de tipo fv de cadena sencilla que reconoce el antígeno c2. su uso en el diagnóstico y tratamiento de tumores colorrectales |
| DE50110712D1 (de) * | 2000-05-24 | 2006-09-21 | Roche Diagnostics Gmbh | Antikörper gegen spezielle formen des propsa und deren verwendung in immunoassays |
| EP1541166B1 (en) | 2001-05-16 | 2007-12-19 | Nymox Corporation | Preventing cell death using segments of neural thread proteins |
| WO2003008443A2 (en) | 2001-07-19 | 2003-01-30 | Nymox Corporation | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| US7317077B2 (en) | 2001-11-16 | 2008-01-08 | Nymox Pharmaceutical Corporation | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| DK1994152T3 (da) * | 2006-02-28 | 2013-03-11 | Nymox Corp | Peptider der er effektive i behandlingen af tumorer og andre tilstande der kræver fjernelse eller destruktion af celler |
-
2007
- 2007-02-28 DK DK07710660.7T patent/DK1994152T3/da active
- 2007-02-28 CA CA002643100A patent/CA2643100A1/en not_active Abandoned
- 2007-02-28 US US11/680,119 patent/US8067378B2/en active Active
- 2007-02-28 BR BRPI0708340-8A patent/BRPI0708340A2/pt not_active Application Discontinuation
- 2007-02-28 JP JP2008556623A patent/JP2009528298A/ja not_active Ceased
- 2007-02-28 MX MX2008010942A patent/MX2008010942A/es not_active Application Discontinuation
- 2007-02-28 ES ES07710660T patent/ES2400920T3/es active Active
- 2007-02-28 PT PT77106607T patent/PT1994152E/pt unknown
- 2007-02-28 EP EP07710660A patent/EP1994152B1/en active Active
- 2007-02-28 SI SI200731180T patent/SI1994152T1/sl unknown
- 2007-02-28 EA EA200801853A patent/EA200801853A1/ru unknown
- 2007-02-28 KR KR1020087023619A patent/KR20080110765A/ko not_active Application Discontinuation
- 2007-02-28 CN CNA2007800067194A patent/CN101389760A/zh active Pending
- 2007-02-28 AU AU2007219669A patent/AU2007219669A1/en not_active Abandoned
- 2007-02-28 PL PL07710660T patent/PL1994152T3/pl unknown
- 2007-02-28 WO PCT/CA2007/000318 patent/WO2007098588A1/en active Search and Examination
-
2008
- 2008-08-27 ZA ZA200807394A patent/ZA200807394B/xx unknown
-
2011
- 2011-11-28 US US13/305,143 patent/US8716247B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007219669A1 (en) | 2007-09-07 |
| US20120114679A1 (en) | 2012-05-10 |
| ES2400920T3 (es) | 2013-04-15 |
| US8716247B2 (en) | 2014-05-06 |
| EP1994152A4 (en) | 2009-04-01 |
| PL1994152T3 (pl) | 2013-05-31 |
| US20080176805A1 (en) | 2008-07-24 |
| EP1994152B1 (en) | 2012-12-12 |
| EA200801853A1 (ru) | 2009-02-27 |
| EP1994152A1 (en) | 2008-11-26 |
| WO2007098588A1 (en) | 2007-09-07 |
| CA2643100A1 (en) | 2007-09-07 |
| PT1994152E (pt) | 2013-03-13 |
| US8067378B2 (en) | 2011-11-29 |
| KR20080110765A (ko) | 2008-12-19 |
| BRPI0708340A2 (pt) | 2011-05-24 |
| CN101389760A (zh) | 2009-03-18 |
| MX2008010942A (es) | 2008-09-03 |
| JP2009528298A (ja) | 2009-08-06 |
| SI1994152T1 (sl) | 2013-05-31 |
| ZA200807394B (en) | 2009-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1994152T3 (da) | Peptider der er effektive i behandlingen af tumorer og andre tilstande der kræver fjernelse eller destruktion af celler | |
| DK2114419T3 (da) | Natriummetaarsenit til anvendelse i behandling af smerte og inflammation | |
| DK2331109T3 (da) | Fremgangsmåder og sammensætninger til behandling af knogledefekter med placentale cellepopulationer | |
| DK2342233T3 (da) | Anti-CXCR4-antistoffer og anvendelse deraf i behandling af cancer | |
| DK2252342T3 (da) | Indretninger og fremgangsmåder til behandling af skadet væv | |
| DK1917246T3 (da) | Benzoquinazolinderivater og deres anvendelse til behandling af knoglesygdomme | |
| DK2483278T3 (da) | Benzoxazepin pi3k-inhibitorforbindelser og deres anvendelse i behandlingen af cancer | |
| DK2146733T3 (da) | Treatment of leaky or damaged tight junctions and enhancing extracellular matrix | |
| DK2470191T3 (da) | Fremgangsmåder og præparater til forebyggelse eller behandling af oftalmiske tilstande | |
| DK2089361T3 (da) | Inhibitorer af natriumglucose-cotransportør 2 og fremgangsmåder til deres anvendelse | |
| DK2480574T3 (da) | Anti-cd33-antistoffer og deres anvendelse til immunotargeting i behandlingen af cd33-associerede sygdomme | |
| DK2155188T3 (da) | Fremgangsmåder og sammensætninger til behandling af tilbagevendende kræft | |
| DK2010331T3 (da) | Fremgangsmåder til udvælgelse og/eller behandling af partikler til selektiv og/eller optimeret lysering af celler | |
| DK1771201T3 (da) | Sammensætninger og fremgangsmåder til behandling eller forebyggelse af oxalat-relateret sygdom | |
| DK1889065T3 (da) | Metoder til diagnostisering og behandling af sygdomme med en autoimmun- og/eller inflammationskomponent | |
| DK2078073T3 (da) | Nyreafledte celler og fremgangsmåder til anvendelse deraf til vævsreparation og -regenerering | |
| DK3327030T3 (da) | Vacciner og vaccinebestanddele til hæmning af mikrobielle celler | |
| DK2306899T3 (da) | Påvisning af hypokinetiske og/eller hyperkinetiske tilstande | |
| BRPI0717325A2 (pt) | Métodos para prevenir retropopulsão de solidificações e fragmentos durante litotripsia | |
| DK1765376T3 (da) | Topiske sammensætninger og anvendelse deraf til behandling af epitel-relaterede tilstande | |
| DK2089047T3 (da) | Sammensætninger og fremgangsmåder til beskyttelse og regenerering af hjerte-væv | |
| BRPI0719519A2 (pt) | Sistemas de descarga e métodos de utilização dos mesmos | |
| DK2235002T3 (da) | 4-pyridinonforbindelser og anvendelse heraf til behandling af cancer | |
| DK2063881T3 (da) | Sammensætning og fremgangsmåde til virksom og sikker administration af halopyruvat til behandlingen af cancer | |
| DK2043671T3 (da) | Peptid og sammensætning deraf til anvendelse ved behandling af slagtilfælde med feber |